Korean J Gastroenterol.  2013 Nov;62(5):313-314. 10.4166/kjg.2013.62.5.313.

Is Infantile Inflammatory Bowel Disease Curable with Hematopoietic Stem Cell Transplantation?

Affiliations
  • 1Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. kojs@snu.ac.kr

Abstract

No abstract available.


MeSH Terms

Female
*Hematopoietic Stem Cell Transplantation
Humans
*Inflammatory Bowel Diseases
Interleukin-10/*genetics
Interleukin-10 Receptor alpha Subunit/*genetics
Interleukin-10 Receptor beta Subunit/*genetics
Male
Interleukin-10
Interleukin-10 Receptor alpha Subunit
Interleukin-10 Receptor beta Subunit

Cited by  2 articles

Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases
Jin Soo Moon
Pediatr Gastroenterol Hepatol Nutr. 2019;22(1):50-56.    doi: 10.5223/pghn.2019.22.1.50.

Clinical aspects and treatments for pediatric inflammatory bowel diseases
Jin Soo Moon
Intest Res. 2019;17(1):17-23.    doi: 10.5217/ir.2018.00139.


Reference

References

1. Kotlarz D, Beier R, Murugan D, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012; 143:347–355.
Article
2. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009; 361:2033–2045.
Article
3. Glocker EO, Frede N, Perro M, et al. Infant colitis–it's in the genes. Lancet. 2010; 376:1272.
Article
4. Begue B, Verdier J, Rieux-Laucat F, et al. Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am J Gastroenterol. 2011; 106:1544–1555.
Article
5. Engelhardt KR, Shah N, Faizura-Yeop I, et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013; 131:825–830.
Article
6. Mao H, Yang W, Lee PP, et al. Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neo-natal-onset Crohn's disease. Genes Immun. 2012; 13:437–442.
Article
7. Shim JO, Hwang S, Yang HR, et al. Interleukin-10 receptor mutations in children with neonatal-onset Crohn's disease and intractable ulcerating enterocolitis. Eur J Gastroenterol Hepatol. 2013; 25:1235–1240.
Article
8. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleu-kin-10-deficient mice develop chronic enterocolitis. Cell. 1993; 75:263–274.
Article
9. Franke A, Balschun T, Karlsen TH, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet. 2008; 40:1319–1323.
Article
10. Amre DK, Mack DR, Morgan K, et al. Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment Pharmacol Ther. 2009; 29:1025–1031.
Article
11. Moran CJ, Walters TD, Guo CH, et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm Bowel Dis. 2013; 19:115–123.
Article
12. Denson LA. How does knowledge from translational research impact our clinical care of pediatric inflammatory bowel disease patients? Curr Gastroenterol Rep. 2012; 14:275–281.
Article
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr